US Supreme Court to Hear Major Abortion Pill Case in March
The decision in the case could determine whether the abortion pill mifepristone can be prescribed by telemedicine or sent through the mail.
The decision in the case could determine whether the abortion pill mifepristone can be prescribed by telemedicine or sent through the mail.
The U.S. Supreme Court has agreed to take up a key abortion case in 2024. The nation’s highest court will weigh in on how patients can access the widely used abortion pill mifepristone. The Register’s National Correspondent Lauretta Brown brings us this story and more from the Register’s coverage of abortion in the United States. But first we get an update on what seems to be a standoff between the Vatican and German Bishops from Jonathan Liedl, who has been reporting on this ongoing story from Rome.
Food and Drug Administration v. Alliance for Hippocratic Medicine comes to the Supreme Court on appeal from a ruling last August by a three-judge panel of the Fifth U.S. Circuit Court of Appeals upholding a district court decision that placed substantial restrictions on the drug.
The struggle to protect unborn human life must continue — in legislatures, courts and the court of public opinion.
The organization’s latest research shows that women who have experienced medication abortions do not know how to find help if they need emotional healing.
They highlight serious concerns with at-home abortions and question the FDA’s reporting system.
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription here.
Subscribe and Save HALF OFF!Start your Register subscription today.
Subscribe NowGive a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up